Search results
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 4 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe UK's National Health Service (NHS) has announced plans to offer Pfizer's Voxelotor (Oxbryta), a...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 4 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 7 hours agoDiscover the latest findings on the return on investment from pharmaceutical...
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 day agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Amazon, Pfizer, Pinterest rise premarket; AMD, Starbucks, CVS Health fall By Investing.com
Investing.com· 4 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 4 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer cervical cancer drug gets full approval
Becker’s Hospital Review· 2 days agoThe FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.